SSGA Active Trust has released its financial results for the third quarter of 2026, as detailed in its recent SEC filing. The report, filed on October 28, 2026, highlights the company's total assets and liabilities, reflecting its strategic positioning in the investment sector.
As of August 31, 2026, SSGA Active Trust reported total assets of approximately $7.22 million and total liabilities of about $38,917. This results in net assets of roughly $7.18 million. The firm’s performance is largely attributed to its management of the SPDR SSGA My2035 Corporate Bond ETF, which is designed to provide investors with exposure to a diversified portfolio of corporate bonds.
SSGA Active Trust is an investment management company based in Boston, Massachusetts. The firm operates under the Central Index Key (CIK) 0001516212 and is known for its innovative investment strategies. The company has undergone name changes in the past, previously known as SSgA Active ETF Trust and SSgA Active Trust.
The filing indicates that the SPDR SSGA My2035 Corporate Bond ETF, identified by series ID S000094664, continues to be a significant focus for the firm. The ETF aims to cater to investors looking for a long-term investment option, with a maturity date set for 2035.
In the latest filing, SSGA Active Trust also provided insights into its investment strategies and the performance of its holdings. Notably, the fund's investments include major corporations such as AT&T Inc., AbbVie Inc., and Apple Inc., among others. This diversified approach aims to mitigate risks while maximizing returns for investors.
Looking ahead, the filing does not specify future actions or additional filings. However, industry analysts and competitors will likely keep a close eye on SSGA Active Trust's performance as it navigates the evolving investment landscape.
Read Next
van Houte Hans Reports Stock Transactions at Nurix Therapeutics
Hansen Gwenn Acquires and Sells Shares at Nurix Therapeutics
Drouillard Vincent Amends Filing to Correct Share Sale Details
Drouillard Vincent reports sale of 10,000 shares in AerCap
Gilead Sciences CEO Daniel O'Day Executes Multiple Stock Sales
Le Peuch Olivier Sells 25,000 Shares of SLB Limited





